Delivery Order SPE2DB20D2014-SPE2DB25FB96B
Award Date
5/15/25
Potential Completion Date
5/16/25
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,042.58 Firm Fixed Price delivery order is for the supply of 4,568,142,696 units of Mitomycin 5 mg vials, with a performance period through May 6, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,219.52, is for the delivery of Mitomycin 5 mg vials, a specialty pharmaceutical product. The contract has an ultimate completion date of November 20, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside requirement, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,250,777 units of Mitomycin 5 mg vials, a chemotherapy medication. The contract has a firm fixed price of $2,751.36 and a completion date of May 15, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Mitomycin 5 mg vials to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,818.90 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of April 11, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $16,942.61 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,235,008 vials of the drug Dactinomycin 500 mcg. The contract has a period of performance ending on May 14, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. government. The contract, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has a ceiling value of $25,656.54 and a completion date of September 3, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,361.00 firm fixed-price delivery order is for the supply of 4,563,309,924 units of Methotrexate 1 GM vials, a critical pharmaceutical product used in various medical treatments. The contract has an ultimate completion date of January 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award, valued at $2,873.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4560862324 - Methylergonovine 0.2 mg/ml vials, with a performance period ending on May 9, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is for the delivery of pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,052.00, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical and medical products to the U.S. government. The contract is for the delivery of the medication MOUNJARO 10 MG/0.5 ML PEN 0.5ML, with a completion date of August 19, 2024. This award is a delivery order under a larger Indefinite Delivery Contract...
This federal contract award is for pharmaceutical and medical supplies to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The delivery order, valued at $1,988.44, is for the drug Myorisan 40 mg capsule and has a completion date of November 30, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...